Acadia Pharmaceuticals reported $10.01M in Trade Creditors for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Acadia Pharmaceuticals ACAD:US USD 10.01M 1.85M
Alnylam Pharmaceuticals ALNY:US USD 40.57M 11.85M
Aptinyx Inc APTX:US USD 474K 1.63M
Biogen BIIB:US USD 383.2M 51.6M
Cara Therapeutics CARA:US USD 15.22M 5.48M
Corcept Therapeutics CORT:US USD 8.18M 68K
Cytokinetics CYTK:US USD 14.43M 351K
Eisai 4523:JP JPY 76.83B 19.28B
Intercept Pharmaceuticals ICPT:US USD 21.3M 9.64M
Intra Cellular Therapies ITCI:US USD 14.22M 3.47M
Marinus Pharmaceuticals MRNS:US USD 1.62M 1.68M
Moderna Inc MRNA:US USD 330M 149M
Prothena PRTA:US USD 9.79M 2.24M
Ptc Therapeutics PTCT:US USD 20.86M 2.02M
Sarepta Therapeutics SRPT:US USD 118.46M 62.25M
Seattle Genetics SGEN:US USD 144.5M 15.63M
Ultragenyx Pharmaceutical RARE:US USD 23.53M 10.68M
Vanda Pharmaceuticals VNDA:US USD 5.58M 36K
Vertex Pharmaceuticals VRTX:US USD 126.9M 71.1M
YTE INCY:US USD 163.17M 31.6M